John B Henneman III has bought stock on 3 days since Oct 2019
Director at Orthofix Medical Inc., and 4 other companies
SEC CIK 0001187572 · Filings on SEC.gov ↗
John B Henneman III's record
3 months after each buy, from the first price a copier could get.
2 buys have 3 months of prices so far. A record shows here at 3.
Companies
Every filing
6 filings since Aug 2018, newest first
Orthofix Medical Inc.
Director
Anika Therapeutics, Inc.
Director
R1 Rcm Inc. /De
Director
Seaspine Holdings Corp
Director
Aprea Therapeutics, Inc.
Director
Seaspine Holdings Corp
Director
About John B Henneman III
John B. Henneman III is a seasoned financial executive serving as a Director on the Board of Anika Therapeutics, Inc. (NASDAQ: ANIK) since September 2020.( He currently holds the position of Lead Independent Director and is a member of the Governance and Nominating Committee, with his Class III directorship term expiring at the 2029 Annual Meeting.(
Henneman brings over 25 years of combined financial and operational experience, including roles as Chief Financial Officer at Integra LifeSciences Holdings Corp. and Executive Vice President and Chief Financial Officer at NewLink Genetics Corporation.( His expertise spans executive leadership, industry experience, financing/accounting, and mergers & acquisitions.( Recently, on May 1, 2026, he purchased 5,000 shares of ANIK at a weighted average price of $14.6639, increasing his direct holdings to 54,871 shares.( He serves as a director at multiple companies, including OFIX, with estimated insider holdings valued at $1.8M across three firms and a personal net worth of approximately $22.3M from reported shares.( Age 64 as of recent filings.(
Written by Perplexity from public sources.
Filings come from SEC EDGAR. Not investment advice.